"sid","Response_Bin","pid","response_NR","response","treatment","Therapy","Drug","biopsy_time","surgery","dataset_id","dataset_group","M.Stage","overall.survival..days.","vital.status","Total.Mutation","Gender","age_start","tumor_type","seq_type","id"
"SRR3184279",0,"Pt1",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1B",607,"Dead",1638,"Female",66,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184280",1,"Pt2",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",927,"Alive",1868,"Male",55,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184281",1,"Pt4",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",948,"Alive",3727,"Male",62,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184282",1,"Pt5",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",439,"Alive",312,"Male",61,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184283",1,"Pt6",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",882,"Alive",207,"Male",51,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184284",0,"Pt7",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",662,"Dead",1184,"Female",55,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184285",1,"Pt8",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1A",NA,"Alive",805,"Male",69,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184286",1,"Pt9",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M0",1054,"Alive",474,"Male",68,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184287",0,"Pt10",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1A",387,"Alive",225,"Male",60,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184288",0,"Pt12",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",327,"Dead",50,"Male",59,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184289",1,"Pt13",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",917,"Alive",428,"Female",53,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184290",0,"Pt14",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",54,"Alive",1457,"Female",27,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184291",1,"Pt15",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1B",980,"Dead",514,"Male",70,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184293",1,"Pt19",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",1060,"Alive",618,"Male",45,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184294",0,"Pt20",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",337,"Dead",542,"Female",63,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184295",0,"Pt22",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",182,"Dead",68,"Male",55,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184296",0,"Pt23",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",103,"Dead",233,"Male",63,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184297",0,"Pt25",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",262,"Dead",110,"Male",74,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184298",1,"Pt27A",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",548,"Alive",2297,"Male",83,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184299",1,"Pt27B",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",548,"Alive",2297,"Male",83,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184300",1,"Pt28",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",439,"Dead",465,"Male",82,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184301",0,"Pt29",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",269,"Dead",225,"Male",84,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184302",0,"Pt31",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",704,"Alive",594,"Male",47,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184303",0,"Pt32",FALSE,"PD","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",171,"Dead",259,"Male",47,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184304",1,"Pt35",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",427,"Alive",313,"Female",65,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184305",1,"Pt37",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",364,"Alive",553,"Female",70,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
"SRR3184306",1,"Pt38",TRUE,"R","PRE","anti-PD-1","pembrolizumab","pre-treatment",NA,"GSE78220","Melanoma_GSE78220","M1C",448,"Alive",78,"Female",57,"Melanoma","RNA-seq","Melanoma_GSE78220_anti-PD-1"
